Compare PGEN & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | EEFT |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2013 | 1996 |
| Metric | PGEN | EEFT |
|---|---|---|
| Price | $7.02 | $62.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $13.65 | ★ $73.00 |
| AVG Volume (30 Days) | ★ 4.5M | 908.8K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.05 |
| EPS | 0.03 | ★ 2.54 |
| Revenue | $230,981,000.00 | ★ $4,244,200,000.00 |
| Revenue This Year | $2,335.22 | $3.12 |
| Revenue Next Year | $85.34 | $4.19 |
| P/E Ratio | $223.17 | ★ $24.35 |
| Revenue Growth | N/A | ★ 6.38 |
| 52 Week Low | $3.04 | $57.48 |
| 52 Week High | $8.98 | $83.97 |
| Indicator | PGEN | EEFT |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 44.27 |
| Support Level | $6.57 | N/A |
| Resistance Level | $7.44 | $74.95 |
| Average True Range (ATR) | 0.42 | 2.27 |
| MACD | -0.03 | -0.13 |
| Stochastic Oscillator | 55.14 | 50.68 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing, and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.